Antiviral and Cytoprotective Effect of Zinc (Yasad Bhasma) Based Nanoformulations Against Bovine Coronavirus

• Published in: Indian journal of microbiology Vol. 64; no. 3; pp. 1123 - 1131
• Main Authors: Manuja, Anju, Kumar, Balvinder, Chhabra, Dharvi, brar, Basanti, Riyesh, T., Pal, Yash, Bhattacharya, T. K., Prasad, Minakshi
• Format: Journal Article
• Language: English
• Published: New Delhi Springer India 01.09.2024; Springer Nature B.V
• Subjects: Alternative medicine; Biocompatibility; Biomedical and Life Sciences; Cell proliferation; Coronaviruses; COVID-19; Hydroxychloroquine; Internalization; Life Sciences; Medical Microbiology; Microbiology; Original Research Article; Vero cells; Zinc; Corona virus; Antiviral; Yasad bhasam; Hydroxychloroquine; Bovine; Zinc
• ISSN: 0046-8991; 0973-7715
• DOI: 10.1007/s12088-024-01255-0

Ayurvedic medicine utilizes metal-based preparations, known as bhasmas, to treat various health conditions. Yasad bhasma (YB), a zinc-based ayurvedic preparation, shows promise as a potential candidate for developing zinc-based nanomedicines with anti-inflammatory and antioxidant properties. In this study, we synthesized a formulation combining YB and hydroxychloroquine (HC) as a zinc ionophore (YBHC) and investigated its biocompatibility and antiviral effects against buffalo calf coronavirus (BCoV) in Vero cells. Our results demonstrated that the formulation exhibited good conformity and enhanced cell proliferation compared to untreated cells. Additionally, no cytopathic effects were observed in BCoV-infected Vero cells treated with YBHC and YB, while infected control cells exhibited cytopathic effects. YB showed cytoprotection by promoting epithelial tissue turnover. We further explored whether YB/YBHC exerted a lysosomotropic effect to produce antiviral effects on coronavirus-adapted Vero cells, but no cell internalization was observed. In addition to the synergistic antiviral effect of YB and HC, YB may play a vital role in rejuvenating affected tissues.